AI-assisted training notably improved pathologist accuracy in HER2-low breast cancer, reducing misclassification and ...

CHICAGO -- Artificial intelligence (AI) assistance appeared to enhance pathologists' accuracy in identifying HER2-low or ...

Assistance from artificial intelligence can potenially increase the number of patients eligible for treatment for HER2-low ...

Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New ...

Researchers at NIT Rourkela have developed an innovative, semiconductor-based biosensor for early breast cancer detection.

Researchers have discovered a set of alterations in the structure and cellular makeup of breast connective tissue – known as ...

Grants will fund use of artificial intelligence to predict cancer evolution during treatment and better match treatments to ...

Speaking at Rising North East Investors Summit, Ambani outlines six commitments to transform the region's digital, ...

Among the companies displaying the strength of Chinese research in oncology at the 2025 ASCO Annual Meeting will be Hutchmed.

Welcome to The Pharma Letter ’s real-time coverage of the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

Reliance Industries chairman Mukesh Ambani has announced a massive Rs 75,000 crore investment in the North-East over the next ...